NCT05531045View on ClinicalTrials.gov

18FFDG PET/CT for Early Evaluation of Chemotherapy Efficacy in Metastatic Colic Adenocarcinoma

Not yet recruitingOBSERVATIONAL
Enrollment

222

Participants

Timeline

Start Date

September 30, 2022

Primary Completion Date

January 31, 2025

Study Completion Date

September 30, 2027

Conditions
Metastatic Colorectal Cancer
Interventions
DIAGNOSTIC_TEST

PET/CT

FDG PET/CT assessed after 2 cycles of chemotherapy with PERCIST criteria

Trial Locations (1)

75010

Hôpital Saint Louis, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT05531045 - 18FFDG PET/CT for Early Evaluation of Chemotherapy Efficacy in Metastatic Colic Adenocarcinoma | Biotech Hunter | Biotech Hunter